S.R. Schill & Associates’s UnitedHealth UNH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-1,634
| Closed | -$832K | – | 80 |
|
|
2024
Q2 | $832K | Buy |
1,634
+3
| +0.2% | +$1.47K | 0.36% | 29 |
|
|
2024
Q1 | $807K | Sell |
1,631
-1,537
| -49% | -$781K | 0.35% | 34 |
|
|
2023
Q4 | $1.67M | Sell |
3,168
-98
| -3% | -$52.3K | 0.74% | 21 |
|
|
2023
Q3 | $1.65M | Buy |
3,266
+102
| +3% | +$50.2K | 0.8% | 20 |
|
|
2023
Q2 | $1.52M | Buy |
3,164
+3
| +0.1% | +$1.47K | 0.69% | 21 |
|
|
2023
Q1 | $1.49M | Sell |
3,161
-407
| -11% | -$196K | 0.69% | 20 |
|
|
2022
Q4 | $1.89M | Sell |
3,568
-140
| -4% | -$74.2K | 0.94% | 20 |
|
|
2022
Q3 | $1.87M | Buy |
3,708
+648
| +21% | +$341K | 1% | 20 |
|
|
2022
Q2 | $1.57M | Buy |
3,060
+2
| +0.1% | +$1K | 0.79% | 21 |
|
|
2022
Q1 | $1.56M | Buy |
3,058
+2
| +0.1% | +$965 | 0.66% | 21 |
|
|
2021
Q4 | $1.53M | Hold |
3,056
| – | – | 0.61% | 21 |
|
|
2021
Q3 | $1.19M | Hold |
3,056
| – | – | 0.51% | 23 |
|
|
2021
Q2 | $1.22M | Sell |
3,056
-200
| -6% | -$79.7K | 0.48% | 26 |
|
|
2021
Q1 | $1.21M | Buy |
3,256
+6
| +0.2% | +$2.08K | 0.53% | 25 |
|
|
2020
Q4 | $1.14M | Sell |
3,250
-927
| -22% | -$311K | 0.53% | 23 |
|
|
2020
Q3 | $1.3M | Sell |
4,177
-119
| -3% | -$36.6K | 0.66% | 21 |
|
|
2020
Q2 | $1.27M | Hold |
4,296
| – | – | 0.74% | 23 |
|
|
2020
Q1 | $1.07M | Sell |
4,296
-378
| -8% | -$104K | 0.72% | 23 |
|
|
2019
Q4 | $1.37M | Hold |
4,674
| – | – | 0.75% | 28 |
|
|
2019
Q3 | $1.02M | Sell |
4,674
-871
| -16% | -$210K | 0.57% | 32 |
|
|
2019
Q2 | $1.35M | Buy |
5,545
+794
| +17% | +$191K | 0.84% | 23 |
|
|
2019
Q1 | $1.18M | Buy |
4,751
+118
| +3% | +$30.1K | 0.71% | 31 |
|
|
2018
Q4 | $1.15M | Sell |
4,633
-73
| -2% | -$19.3K | 0.81% | 26 |
|
|
2018
Q3 | $1.25M | Sell |
4,706
-125
| -3% | -$32.5K | 0.77% | 28 |
|
|
2018
Q2 | $1.19M | Buy |
4,831
+60
| +1% | +$14.4K | 0.73% | 29 |
|
|
2018
Q1 | $1.02M | Buy |
4,771
+934
| +24% | +$213K | 0.63% | 34 |
|
|
2017
Q4 | $846K | Buy |
3,837
+24
| +0.6% | +$5.09K | 0.52% | 39 |
|
|
2017
Q3 | $747K | Buy |
3,813
+330
| +9% | +$63.8K | 0.45% | 39 |
|
|
2017
Q2 | $646K | Hold |
3,483
| – | – | 0.41% | 38 |
|
|
2017
Q1 | $571K | Buy |
3,483
+815
| +31% | +$133K | 0.36% | 44 |
|
|
2016
Q4 | $427K | Sell |
2,668
-5
| -0.2% | -$747 | 0.28% | 50 |
|
|
2016
Q3 | $374K | Hold |
2,673
| – | – | 0.25% | 56 |
|
|
2016
Q2 | $377K | Sell |
2,673
-15
| -0.6% | -$2K | 0.25% | 49 |
|
|
2016
Q1 | $346K | Buy |
2,688
+355
| +15% | +$42K | 0.23% | 52 |
|
|
2015
Q4 | $274K | Sell |
2,333
-154
| -6% | -$18K | 0.19% | 57 |
|
|
2015
Q3 | $289K | Buy |
2,487
+577
| +30% | +$69.1K | 0.21% | 58 |
|
|
2015
Q2 | $233K | Buy |
+1,910
| New | +$226K | 0.16% | 64 |
|
Other funds holding UNH
S.R. Schill & Associates's UNH Position: Q3 2024 in Review
S.R. Schill & Associates sold out of UnitedHealth (UNH) in Q3 2024, closing a stake of 1,634 shares — an estimated $832K sold.
S.R. Schill & Associates first reported a position in UNH in Q2 2015 and held it in 37 quarters. The position peaked at $1.89M in Q4 2022. 3,465 funds tracked by Wall St. Rank hold UNH as of Q3 2024.
- S.R. Schill & Associates reported no remaining UnitedHealth position as of Q3 2024 after selling out during the quarter.
- S.R. Schill & Associates sold 1,634 UnitedHealth shares in Q3 2024, an estimated $832K.
- S.R. Schill & Associates first reported a position in UnitedHealth in Q2 2015 and held it in 37 quarters.
- S.R. Schill & Associates's UnitedHealth position peaked at $1.89M in Q4 2022.
- 3,465 funds tracked by Wall St. Rank held UnitedHealth as of Q3 2024.
Based on S.R. Schill & Associates's 13F filing for Q3 2024, filed 13 Nov 2024.